Gene · 6281
Papers4,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Disulphide Bonds in Membrane Partitioning of a Viral Peptide. | J Membr Biol | 2022 | 35218393 | PubTator, text mining | PubMed |
| The prognostic value of S100A calcium binding protein family members in predicting severe forms of COVID-19. | Inflamm Res | 2022 | 35217896 | PubTator, text mining | PubMed |
| Comparison of Different Mass Spectrometry Workflows for the Proteomic Analysis of Tear Fluid. | Int J Mol Sci | 2022 | 35216421 | PubTator, text mining | PubMed |
| Detection and Characterisation of an Endogenous Betaretrovirus in Australian Wild Deer. | Viruses | 2022 | 35215845 | PubTator, text mining | PubMed |
| Presence of Recombinant Bat Coronavirus GCCDC1 in Cambodian Bats. | Viruses | 2022 | 35215769 | PubTator, text mining | PubMed |
| Effectiveness of Self-Assembling Peptide (P11-4) in Dental Hard Tissue Conditions: A Comprehensive Review. | Polymers (Basel) | 2022 | 35215706 | PubTator, text mining | PubMed |
| Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis. | Pharmaceutics | 2022 | 35214143 | PubTator, text mining | PubMed |
| ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis. | Front Oncol | 2022 | 35211410 | PubTator, text mining | PubMed |
| A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2. | Mol Ther Nucleic Acids | 2022 | 35211356 | PubTator, text mining | PubMed |
| BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis. | Life (Basel) | 2022 | 35207544 | PubTator, text mining | PubMed |
| Trafficking of Annexins during Membrane Repair in Human Skeletal Muscle Cells. | Membranes (Basel) | 2022 | 35207075 | PubTator, text mining | PubMed |
| Changes in Serum N-Glycome for Risk Drinkers: A Comparison with Standard Markers for Alcohol Abuse in Men and Women. | Biomolecules | 2022 | 35204742 | PubTator, text mining | PubMed |
| Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2). | Biomolecules | 2022 | 35204713 | PubTator, text mining | PubMed |
| The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. | Biomolecules | 2022 | 35204653 | PubTator, text mining | PubMed |
| The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology. | Diagnostics (Basel) | 2022 | 35204508 | PubTator, text mining | PubMed |
| Involvement of Inflammasome Components in Kidney Disease. | Antioxidants (Basel) | 2022 | 35204131 | PubTator, text mining | PubMed |
| Correction: Raasakka, A.; Kursula, P. Flexible Players within the Sheaths: The Intrinsically Disordered Proteins of Myelin in Health and Disease. Cells 2020, 9, 470. | Cells | 2022 | 35203407 | PubTator, text mining | PubMed |
| Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. | Toxins (Basel) | 2022 | 35202165 | PubTator, text mining | PubMed |
| Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment. | Front Oncol | 2022 | 35198448 | PubTator, text mining | PubMed |
| Dynamic disequilibrium-based pathogenicity model in mutated pyrin's B30.2 domain-Casp1/p20 complex. | J Genet Eng Biotechnol | 2022 | 35190906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/papers?page=51